Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
17
October
2018
Publication date Collection: 2018
Volume: 13
Issue: 10
Electronic Location Identifier: e0200043
Affiliations
[001]Karyopharm Therapeutics, Department of Neurofegenerative and Infectious Diseases,
Newton, Massachussets, United States of America
Rational Vaccines Inc, UNITED STATES
Author notes
Competing Interests: All authors of this manuscript are employed by, and hold stake in, Karyopharm Therapeutics,
developer and marketer of SINE compounds. This does not alter our adherence to PLOS
ONE policies on sharing data and materials.
Author information
Article
Publisher ID:
PONE-D-18-17280
DOI: 10.1371/journal.pone.0200043
PMC ID: 6192554
PubMed ID: 30332435
SO-VID: 9c335bc0-85fd-418c-859a-959be54b9a8f
Copyright © © 2018 Widman et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by: funder-id http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
Award ID: Contract No. HHSN272201100016I; Task Order HHSN27200005
Award Recipient
:
Sharon Tamir
Funded by: funder-id http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
Award ID: Contract No. HHSN272201100013I; Task Order HHSN27200006
Award Recipient
:
Sharon Tamir
All authors of this manuscript are employed by, and hold stake in, Karyopharm Therapeutics,
developer and marketer of SINE compounds. The funder (Karyopharm) provided support
in the form of salaries for authors [DGW, SG, SS, and ST] but did not have any additional
role in the study design, data collection and analysis, decision to publish, or preparation
of the manuscript. The specific roles of these authors are articulated in the ‘author
contributions’ section. This project has been funded with federal funds from the Division
of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Department of Health and Human Services,
under contract no. HHSN272201100006I task order number HHSN27200005 and contract no.
HHSN272201100013I task order number HHSN27200006 (ST).
Subject:
Research Article
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Virology
Subject:
Viral Replication
Subject:
Biology and Life Sciences
Subject:
Toxicology
Subject:
Cytotoxicity Assay
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Toxicology
Subject:
Cytotoxicity Assay
Subject:
Medicine and Health Sciences
Subject:
Infectious Diseases
Subject:
Opportunistic Infections
Subject:
Biology and Life Sciences
Subject:
Toxicology
Subject:
Cytotoxicity
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Toxicology
Subject:
Cytotoxicity
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
DNA viruses
Subject:
Herpesviruses
Subject:
Epstein-Barr virus
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Medical microbiology
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Herpesviruses
Subject:
Epstein-Barr virus
Subject:
Medicine and health sciences
Subject:
Pathology and laboratory medicine
Subject:
Pathogens
Subject:
Microbial pathogens
Subject:
Viral pathogens
Subject:
Herpesviruses
Subject:
Epstein-Barr virus
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral pathogens
Subject:
Herpesviruses
Subject:
Epstein-Barr virus
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Virology
Subject:
Viral Transmission and Infection
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
DNA viruses
Subject:
Herpesviruses
Subject:
Human Cytomegalovirus
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Herpesviruses
Subject:
Human Cytomegalovirus
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Herpesviruses
Subject:
Human Cytomegalovirus
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral Pathogens
Subject:
Herpesviruses
Subject:
Human Cytomegalovirus
Subject:
Medicine and Health Sciences
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Cytomegalovirus Infection